Home
Resource
Revisiting strategic motives, location choices, and impacts of international research and development
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(1.39 MB)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Nuruzzaman, Nuruzzaman. Revisiting strategic motives, location choices, and impacts of international research and development. Retrieved from https://doi.org/doi:10.7282/t3-k6cy-by81

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

TitleRevisiting strategic motives, location choices, and impacts of international research and development
NameNuruzzaman, Nuruzzaman (author); Gaur, Ajai (chair); Rutgers University; Graduate School - Newark
Date Created2020
Other Date2020-10 (degree)
SubjectInternational research and development, Management
Extent1 online resource (ix, 166 pages)
DescriptionInternationalization of research and development (R&D) by multinational companies is an important topic in the field of international management. Understanding international R&D is a crucial element in understanding globalization, especially in the age of knowledge and information. The purpose of this dissertation is to examine the strategic motives, location choices, and impact of international. I first take stock of the progress in the literature of international R&D by conducting a textual review of existing studies. Furthermore, I examine the strategic motives, location choices, and the impacts of international R&D in two essays.

In the first essay, I examine the strategic motive and location choices of international R&D from the perspective of institutions arbitrage. I propose that the R&D internationalization is also driven by the institutions-arbitraging motives, in which firms seek locations with lax ethical standards to avoid or lower regulatory compliance costs in R&D. The institutions-arbitraging motive encourages firms to seek locations with weak regulatory enforcements to avoid the monitoring of regulatory compliance costs or to avoid potential litigation costs from conducting unethical experiments. I further argue that the likelihood of pharmaceutical firms in selecting locations with lower ethical standards or weaker regulatory enforcement is heterogeneous, depending on the firm’s performance relative to the industry average. I find that firms underperformed firms are more likely to choose locations with low ethical standards or weaker regulatory enforcements than firms with above-average performance.

In the second essay, I examine the domestic impact of international R&D. Based on cost-saving arguments from economic theories as well as the knowledge-augmenting argument from strategic management literature, I propose that the expansion of foreign R&D is associated with the growth of domestic R&D. However, such a positive association is contingent upon the availability of high- and low-discretion slack resources. I argue that because they can provide flexibility for managers to expand innovative activities, high-discretion slack resources strengthen the positive association between foreign R&D and domestic R&D. On the contrary, the accumulation of low-discretion slack resources constraints the selection of R&D projects.

To test my hypotheses, I take advantage of information from clinical trial projects of American-based pharmaceutical firms. My data cover 18 year period from 2000 to 2017. The empirical analyses largely support my arguments.
NotePh.D.
NoteIncludes bibliographical references
Genretheses, ETD doctoral
Persistent URLhttps://doi.org/doi:10.7282/t3-k6cy-by81
LanguageEnglish
CollectionGraduate School - Newark Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024